DPI, the first nasal glucagon preparation for hypoglycaemia

Baqsimi has been approved for nasal application in Germany since 01/03/2020. It does not need to be stored in the refrigerator like injectable glucagon. After response to the administered dose, carbohydrates should be administered orally to replenish the hepatic glycogen stores to prevent re-hypoglycaemia.

https://www.gelbe-liste.de/diabetologie/baqsimi-diabetes-unterzuckerung